Alpha Gliadin IgA

If bloating, diarrhea, unexplained fatigue, or stubborn anemia has you wondering whether wheat is the culprit, this is one of the antibody tests that can flag an immune reaction to gluten. It is an older marker with a real but narrow role.

A positive result is fairly specific for celiac disease, but it misses many people who actually have it, and newer blood tests have largely replaced it. Knowing what it can and cannot tell you is the difference between a useful clue and a misleading one.

What This Test Actually Measures

This test measures alpha-gliadin IgA, meaning IgA (immunoglobulin A, one of the antibody types your body makes, especially along the lining of your gut) aimed at alpha-gliadin, one of the proteins inside wheat gluten. A high level reflects that your immune system is producing antibodies against dietary gluten. It signals an immune reaction, but it does not by itself measure damage to your gut.

Although this marker often sits inside an allergy panel, it is not a food-allergy test in the usual sense. Classic wheat allergy is driven by a different antibody class (IgE), while gliadin IgA reflects a celiac-type response, the kind tied to celiac disease, an immune reaction to gluten that damages the lining of the small intestine. Evidence about wheat IgE allergy does not apply to this IgA result.

The Celiac Disease Signal

The clearest evidence comes from people with celiac disease tested for IgA against a specific fragment of alpha-gliadin. In that work, the antibody was very specific for celiac disease (98%) but only moderately sensitive (56%), meaning it rarely showed up in people without the disease yet caught only a bit more than half of those who had it. It was found in 29 of 72 (40.2%) patients who were already positive on another celiac marker, and every one of them had celiac disease.

The antibody also tracks with active gluten in the diet. It was present while patients were eating gluten and declined once they went gluten-free. Modern guidelines still favor tTG-IgA (an antibody against tissue transglutaminase, the enzyme most closely tied to celiac damage) plus a total IgA measurement over gliadin-based antibodies for a first look.

Source: Bateman et al., Gut 2004 (alpha-gliadin fragment); Sugai et al., Clin Gastroenterol Hepatol 2006 (conventional anti-gliadin IgA); Rouvroye et al., J Neurol 2025 (neurologic cohort).

What this means for you: a positive result raises the odds of celiac disease enough to take seriously, but the test earns its keep only as part of a fuller workup. Outside the gut, the same standard-cutoff antibody did not separate people with nerve and balance disorders from healthy controls, so a result there carries little weight on its own.

Why a Negative Result Does Not Rule Celiac Disease Out

Because sensitivity is only moderate, a normal result misses a meaningful share of people who genuinely have celiac disease. This is the main reason it is no longer used alone. In one pediatric series, 2 of 24 children with confirmed celiac disease were positive on this gliadin antibody only, while other confirmed cases were negative on it but positive on different tests, showing that no single celiac antibody catches everyone.

If you have symptoms that point to celiac disease, a negative gliadin IgA should not end the conversation. Pairing it with tTG-IgA, a total IgA level, and sometimes EMA (endomysial antibodies, another celiac marker read under a microscope) gives a far more reliable picture.

Why a Positive Result Is Not Proof

A common assumption is that a positive gliadin antibody equals celiac disease. The evidence does not support treating it that way. Older gliadin antibody assays also turn up in other gut and immune conditions, so the result is a specific-but-imperfect flag rather than a diagnosis.

The way to hold both facts together is to see this as a phenotype clue, not a yes-or-no verdict. A raised level makes celiac disease more likely, but it can also reflect other processes, which is exactly why a positive result should be confirmed with celiac-specific testing before you change anything. Raised IgA anti-gliadin was reported in about 70% (19 of 27) of people with a kidney condition called IgA nephropathy in a 1987 study, though a larger 2014 study found no significant increase, so that link is uncertain. Elevated levels have also been seen in people with psoriatic arthritis, showing that positivity is not unique to celiac disease. In infants first exposed to gluten, a transient positive result appeared in about 12% (59 of 475) and did not predict later celiac disease at all.

Why One Reading Is Not Enough

This antibody rises and falls with gluten exposure, which makes a single snapshot easy to misread. Its most durable use is tracking a trend over time rather than reading one number. In people with diagnosed celiac disease, the level declined after switching to a gluten-free diet, so serial testing can show whether the immune reaction is quieting down. That said, current guidelines favor tTG-IgA over gliadin IgA for tracking the response to a gluten-free diet.

A practical rhythm: get a baseline while you are still eating gluten, and if you make dietary changes, retest in 3 to 6 months to see the direction of travel, then at least annually if you are managing a known gluten-related condition. The trajectory tells you more than any one value, especially since the reading depends heavily on what you have been eating.

What an Unexpected Result Should Prompt

If your gliadin IgA comes back positive, the next move is confirmation rather than a diet change. Order tTG-IgA, a total IgA level, and consider EMA-IgA, and speak with a gastroenterologist about whether a small-intestine biopsy is warranted. Do not start a gluten-free diet before the workup is complete, because doing so can erase the very signals these tests rely on.

If your result is negative but your symptoms persist, the workup is not finished. Check a total IgA level to rule out IgA deficiency, add tTG-IgA and DGP (deamidated gliadin peptide antibodies, a newer gluten-based test), and in borderline or conflicting cases, genetic celiac testing can help clarify the picture. Combinations of findings, not a single antibody, should drive the decision.

When Results Can Be Misleading

• IgA deficiency: if your body makes little or no IgA (an inherited condition), every IgA-based celiac test, including this one, can read falsely negative, which is why a total IgA level is checked alongside it.
• Already gluten-free: because the antibody fades once gluten is removed, testing after you have cut gluten can produce a falsely low result and hide an underlying reaction.
• Non-celiac positivity: raised gliadin IgA also appears in other gut and immune conditions, so a positive result outside a celiac evaluation is easy to over-read.
• Assay differences: older native-gliadin tests vary between labs and are less specific than newer gluten-based assays, so the same sample can give different numbers depending on the method.